[
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2026",
    "title": "Kvartalsrapport Q2 2026",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a2d4ce634319b47e67508fcb6cb34241c",
    "date": "2026-07-16",
    "period": "2026-q2",
    "form_type": "interim-report",
    "report_key": "2026:q2",
    "filename": "07159325.pdf",
    "text_chars": 95367,
    "sha256": "a34cda4a5b706a0431497a4779e306b88014ff959e91108f7004b7bc5bf7176f",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2026/part-001.html",
        "chars": 95367
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
    "title": "Kvartalsrapport Q1 2026",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a8a7a6601c2707c4b51e02e890746db2f",
    "date": "2026-04-28",
    "period": "2026-q1",
    "form_type": "interim-report",
    "report_key": "2026:q1",
    "filename": "04274767.pdf",
    "text_chars": 81834,
    "sha256": "b17b8a3e88ae51823e04f53e569bec75bad8751bc3b6465fb285cb18dccd5eb6",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
        "chars": 81834
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-arsredovisning-2025",
    "title": "Årsredovisning 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a803413b852d7619e00ffe60a724e1771",
    "date": "2026-03-31",
    "period": "2025-annual",
    "form_type": "annual-report",
    "report_key": "2025:annual",
    "filename": "03260875.pdf",
    "text_chars": 803680,
    "sha256": "fd8fcf28461ff21c27a6d013e4c251d1b92a88ace95916316406226328217ab2",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
        "chars": 177160
      },
      {
        "number": 2,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
        "chars": 178827
      },
      {
        "number": 3,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-003.html",
        "chars": 174083
      },
      {
        "number": 4,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-004.html",
        "chars": 179401
      },
      {
        "number": 5,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2025/part-005.html",
        "chars": 94201
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
    "title": "Kvartalsrapport Q4 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a2dc581a992b369dca4b24f3a09c91ce2",
    "date": "2026-02-05",
    "period": "2025-q4",
    "form_type": "year-end-report",
    "report_key": "2025:q4",
    "filename": "02046223.pdf",
    "text_chars": 87369,
    "sha256": "a2cc733202c349e0f23a0a66ad6511d755bc8758dc925ee45b1992f67c565298",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
        "chars": 87369
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
    "title": "Kvartalsrapport Q3 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/ad0ebc4a6d6b69a0d790480924eecfcce",
    "date": "2025-10-20",
    "period": "2025-q3",
    "form_type": "interim-report",
    "report_key": "2025:q3",
    "filename": "10195737.pdf",
    "text_chars": 95082,
    "sha256": "36fffff42260f19d0513ca423002caaf2a7bd69d24200999387039e4c8e89fb0",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
        "chars": 95082
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
    "title": "Kvartalsrapport Q2 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/abaad6a191845e90e57292d3057ecd186",
    "date": "2025-07-16",
    "period": "2025-q2",
    "form_type": "interim-report",
    "report_key": "2025:q2",
    "filename": "07159972.pdf",
    "text_chars": 85283,
    "sha256": "4af6df9a017876eecf7a09b68e407080a211b7644ca383f2d0e87921598bd92a",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
        "chars": 85283
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
    "title": "Kvartalsrapport Q1 2025",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a845fd2722e07b9aaa05e3d2cfbc26000",
    "date": "2025-04-29",
    "period": "2025-q1",
    "form_type": "interim-report",
    "report_key": "2025:q1",
    "filename": "04283614.pdf",
    "text_chars": 71886,
    "sha256": "a1cfb110b5623431908cb455ccdfc00c62ef13dbaa377bfe543b42a76805f04b",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
        "chars": 71886
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-arsredovisning-2024",
    "title": "Årsredovisning 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a0959a7d05a6fcf8fe7bdfb639249c3e8",
    "date": "2025-03-31",
    "period": "2024-annual",
    "form_type": "annual-report",
    "report_key": "2024:annual",
    "filename": "03277258.pdf",
    "text_chars": 712072,
    "sha256": "e58e5e6fcae3dbe82a8cd98cd91edb16a2c34d325a055692239bceaec4aa5447",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
        "chars": 179806
      },
      {
        "number": 2,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
        "chars": 177327
      },
      {
        "number": 3,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-003.html",
        "chars": 176398
      },
      {
        "number": 4,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2024/part-004.html",
        "chars": 178535
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
    "title": "Kvartalsrapport Q4 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a023e6a80152f1c92f009fd9ee16a0933",
    "date": "2025-02-05",
    "period": "2024-q4",
    "form_type": "year-end-report",
    "report_key": "2024:q4",
    "filename": "02041851.pdf",
    "text_chars": 82419,
    "sha256": "f6caa376e1fd958c217d3fb05b7e9aeaac3999cfadcbba3c24142f35df417f69",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
        "chars": 82419
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
    "title": "Kvartalsrapport Q3 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a663c36aa30977493cbca55d44f3473e8",
    "date": "2024-10-24",
    "period": "2024-q3",
    "form_type": "interim-report",
    "report_key": "2024:q3",
    "filename": "10236498.pdf",
    "text_chars": 83194,
    "sha256": "5ba80e24f38d110e6f69c5f05792486b46fc677a43532d649903d6d1dc6212a6",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
        "chars": 83194
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
    "title": "Kvartalsrapport Q2 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a30f3433f133728239646c72979408bc8",
    "date": "2024-07-16",
    "period": "2024-q2",
    "form_type": "interim-report",
    "report_key": "2024:q2",
    "filename": "07155900.pdf",
    "text_chars": 79272,
    "sha256": "2beb780fc696e0cdc36ad6c847af8ea887fe5173fc37488471dcb4866a564363",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
        "chars": 79272
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
    "title": "Kvartalsrapport Q1 2024",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a859af69b59fde0bbeaea3f650018db9f",
    "date": "2024-04-25",
    "period": "2024-q1",
    "form_type": "interim-report",
    "report_key": "2024:q1",
    "filename": "04247488.pdf",
    "text_chars": 72854,
    "sha256": "93cce24ab1bc25e4919a1340756e72ba8c5e1d74aa66fce087ca8ff1982ac26b",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
        "chars": 72854
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-arsredovisning-2023",
    "title": "Årsredovisning 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a3a0129a40ccc4e88990e701eed9d58fb",
    "date": "2024-04-02",
    "period": "2023-annual",
    "form_type": "annual-report",
    "report_key": "2023:annual",
    "filename": "03273911.pdf",
    "text_chars": 610135,
    "sha256": "2e692ad7e8c497878cdca331763d72469c7bd11f6d110bdcf44968032bd28cb4",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
        "chars": 171277
      },
      {
        "number": 2,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
        "chars": 179719
      },
      {
        "number": 3,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-003.html",
        "chars": 175384
      },
      {
        "number": 4,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-arsredovisning-2023/part-004.html",
        "chars": 83749
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
    "title": "Kvartalsrapport Q4 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/adde0b322dea3c5b52faacfe607f60b9c",
    "date": "2024-02-08",
    "period": "2023-q4",
    "form_type": "year-end-report",
    "report_key": "2023:q4",
    "filename": "02073988.pdf",
    "text_chars": 80677,
    "sha256": "69fd59510737bbc9c3bfa404f2cf4c3af955915b786cbf5564668e7451ad055b",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
        "chars": 80677
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
    "title": "Kvartalsrapport Q3 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/a7c69cbef88bfba2017353bab0c4b272f",
    "date": "2023-10-30",
    "period": "2023-q3",
    "form_type": "interim-report",
    "report_key": "2023:q3",
    "filename": "10284167.pdf",
    "text_chars": 81081,
    "sha256": "dbf191c8acb11841235477fa308d2ff22f5521f309168824aede1b306863c4ae",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
        "chars": 81081
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
    "title": "Kvartalsrapport Q2 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/ad1ceec26e0bd18055c21d64818ce3a6b",
    "date": "2023-07-18",
    "period": "2023-q2",
    "form_type": "interim-report",
    "report_key": "2023:q2",
    "filename": "07174924.pdf",
    "text_chars": 84136,
    "sha256": "7234f04db1009d9a9039d6b0c0fc4820db51d777a11f09d99f2df0904ffde798",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
        "chars": 84136
      }
    ]
  },
  {
    "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
    "title": "Kvartalsrapport Q1 2023",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://attachment.news.eu.nasdaq.com/aa660dc1176676aee312b120c11a1d606",
    "date": "2023-04-27",
    "period": "2023-q1",
    "form_type": "interim-report",
    "report_key": "2023:q1",
    "filename": "04267261.pdf",
    "text_chars": 69614,
    "sha256": "f3cc4e5143ede980a0eab03e39b37a19d68a2704e3634614ab759118d70f1bda",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
        "chars": 69614
      }
    ]
  },
  {
    "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
    "title": "MFN bolagssida och bolagsmetadata",
    "source": "MFN",
    "source_class": "mfn",
    "source_url": "https://mfn.se/all/a/swedish-orphan-biovitrum",
    "date": null,
    "period": null,
    "form_type": "company-page",
    "report_key": null,
    "filename": "company.txt",
    "text_chars": 15879,
    "sha256": "db955449898c86fa5d2ec49d216074dc77685807a667eb506454dc23daf2b5f5",
    "url": "/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
    "absolute_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
    "txt_url": "/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
    "absolute_txt_url": "https://spela.port0.org/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
    "parts": [
      {
        "number": 1,
        "url": "/company/swedish-orphan-biovitrum-ab/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
        "chars": 15879
      }
    ]
  }
]